UBE2A Antibodies

Santa Cruz Biotechnology delivers a wide array of UBE2A monoclonal antibodies for research focused on understanding UBE2A's role in cellular processes. The monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). UBE2A, a member of the ubiquitin-conjugating enzyme family, plays a central role in the ubiquitin-proteasome system, which is essential for protein degradation and regulation of various cellular functions. UBE2A participates in DNA repair, cell cycle regulation, and response to oxidative stress, making it crucial for maintaining cellular homeostasis and preventing disease. Research has shown that UBE2A dysfunction can lead to various pathological conditions, including cancer and neurodegenerative disorders. Investigating UBE2A's molecular mechanisms and interactions provides valuable insights into disease development and potential therapeutic strategies. Understanding UBE2A's cellular distribution and expression patterns helps reveal its biological significance and regulatory mechanisms. Studying UBE2A's role in protein degradation pathways advances knowledge about cellular quality control systems. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of UBE2A's role in health and disease, contributing to the development of new therapeutic approaches.